NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,279 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,279 Papers indexed
1,440 Papers AI scored
40,279 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-10 10:15 AM
1 Sensitive LC-MS/MS Method for Simultaneous Quantification of Alectinib and Its Major Metabolite M4 in Limited-Volume Human Plasma. Biomedical chromatography : BMC — Nov 10, 2026 2 Patient reimbursement in therapeutic cancer clinical trials: An 18-year multicenter experience. Cancer — Nov 10, 2026 3 Avoid, repair, tolerate: emerging mechanisms of MAP therapy resistance in osteosarcoma. Biological chemistry — Nov 10, 2026 4 Peritoneal metastasis of histone 3 lysine 27-to-methionine-mutant diffuse midline glioma via ventriculoperitoneal shunt: laparoscopic confirmation of occult disease and the need for multimodal liquid biopsy. BMJ case reports — Nov 10, 2026 5 Nanotechnology-enabled drug delivery for retinoblastoma: formulation strategies, ocular targeting and translational perspectives. Nanomedicine (London, England) — Nov 10, 2026 6 Outcomes of Proton Beam Therapy in Infants and Very Young Children. Practical radiation oncology — Nov 10, 2026 7 A "Hot" Sulfur Colloid Clue in a Hypervascular Pediatric Liver Mass: Resolving a Large Focal Nodular Hyperplasia Mimicking Fibrolamellar Hepatocellular Carcinoma. Clinical nuclear medicine — Nov 10, 2026 8 Investigating the Effect of Synbiotic Supplementation on Inflammatory Indices in Critically Ill Septic Children: a Triple Blind Randomized Controlled Trial. Probiotics and antimicrobial proteins — Nov 10, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40279 results
D
Characteristics and outcomes of newly diagnosed pediatric acute myeloid leukemia patients who were removed from standard regimens and received alternative therapy.
PMID 40400478 Published: 2025-05-22 Ingested: 2026-08-02 12:12 AM Haematologica
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
PMID 40393961 Published: 2025-05-20 Ingested: 2026-08-02 12:04 AM Blood cancer journal
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Treatment for paraplegia due to severe kyphoscoliosis associated with neurofibromatosis type 1 via halo-pelvic traction: a case report.
PMID 40390097 Published: 2025-05-19 Ingested: 2026-08-02 12:04 AM Journal of medical case reports
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Case Report: Living donor liver transplantation for the treatment of recurrent pediatric acute liver failure with neuroblastoma amplified sequence gene mutation: a literature review.
PMID 40370974 Published: 2025-04-30 Ingested: 2026-08-02 12:03 AM Frontiers in pediatrics
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Use of Animal-assisted Therapy in Children With Cancer.
PMID 40262055 Published: 2025-04-21 Ingested: 2026-08-02 12:04 AM Journal of pediatric hematology/oncology
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Correction: Management and outcome of children with high‑risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.
PMID 40202583 Published: 2025-08-01 Ingested: 2026-08-02 12:05 AM Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
CORR Insights®: Can We Accurately Predict Adult Height in Pediatric Patients Who Undergo Treatment for Sarcoma?
PMID 40198311 Published: 2025-04-09 Ingested: 2026-08-02 12:04 AM Clinical orthopaedics and related research
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
A Novel TAL2::TCRB Fusion With PI3K/AKT Pathway Mutations in Pediatric T-Cell Acute Lymphoblastic Leukemia: Diagnostic and Therapeutic Implications.
PMID 40150826 Published: 2025-03-27 Ingested: 2026-08-02 12:03 AM Pediatric blood & cancer
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Successful treatment of pediatric mature B-cell lymphoma with MYC and BCL6 rearrangements.
PMID 40121562 Published: 2025-01-01 Ingested: 2026-08-02 12:03 AM Pediatrics international : official journal of the Japan Pediatric Society
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Adult height and growth hormone therapy in childhood acute lymphoblastic leukemia survivors treated with total body irradiation and hematopoietic stem cell transplantation before puberty.
PMID 40033132 Published: 2025-03-03 Ingested: 2026-08-02 12:04 AM Bone marrow transplantation
AI -
Standard 49.74
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 49.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

Previous
Page 2944 of 3357
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic